Biomarin Pharmaceutical Inc (BMRN)
63.44
+0.88
(+1.41%)
USD |
NASDAQ |
Nov 21, 16:00
63.44
0.00 (0.00%)
After-Hours: 19:51
Biomarin Pharmaceutical Market Cap: 12.09B for Nov. 21, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 20, 2024 | 11.92B |
| November 19, 2024 | 11.81B |
| November 18, 2024 | 11.80B |
| November 15, 2024 | 12.09B |
| November 14, 2024 | 12.50B |
| November 13, 2024 | 12.70B |
| November 12, 2024 | 12.60B |
| November 11, 2024 | 12.65B |
| November 08, 2024 | 12.78B |
| November 07, 2024 | 12.76B |
| November 06, 2024 | 12.61B |
| November 05, 2024 | 12.59B |
| November 04, 2024 | 12.58B |
| November 01, 2024 | 12.69B |
| October 31, 2024 | 12.56B |
| October 30, 2024 | 12.71B |
| October 29, 2024 | 13.32B |
| October 28, 2024 | 13.37B |
| October 25, 2024 | 13.29B |
| October 24, 2024 | 13.41B |
| October 23, 2024 | 13.33B |
| October 22, 2024 | 13.44B |
| October 21, 2024 | 13.39B |
| October 18, 2024 | 13.36B |
| October 17, 2024 | 13.24B |
| Date | Value |
|---|---|
| October 16, 2024 | 13.37B |
| October 15, 2024 | 13.43B |
| October 14, 2024 | 13.39B |
| October 11, 2024 | 13.41B |
| October 10, 2024 | 13.31B |
| October 09, 2024 | 13.30B |
| October 08, 2024 | 13.09B |
| October 07, 2024 | 13.14B |
| October 04, 2024 | 13.25B |
| October 03, 2024 | 12.99B |
| October 02, 2024 | 13.27B |
| October 01, 2024 | 13.36B |
| September 30, 2024 | 13.39B |
| September 27, 2024 | 13.44B |
| September 26, 2024 | 13.37B |
| September 25, 2024 | 13.14B |
| September 24, 2024 | 13.23B |
| September 23, 2024 | 13.16B |
| September 20, 2024 | 13.46B |
| September 19, 2024 | 13.60B |
| September 18, 2024 | 13.54B |
| September 17, 2024 | 13.43B |
| September 16, 2024 | 13.30B |
| September 13, 2024 | 16.16B |
| September 12, 2024 | 16.06B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
11.80B
Minimum
Nov 18 2024
23.74B
Maximum
Jul 20 2020
16.09B
Average
15.90B
Median
Market Cap Benchmarks
| Merck & Co Inc | 252.58B |
| Bristol-Myers Squibb Co | 118.12B |
| Pfizer Inc | 142.44B |
| Biogen Inc | 23.00B |
| Moderna Inc | 14.72B |
Market Cap Related Metrics
| PE Ratio | 37.99 |
| PS Ratio | 4.525 |
| PEG Ratio | 0.3240 |
| Price to Book Value | 2.233 |
| Price to Free Cash Flow | 41.40 |
| Price | 63.44 |
| Earnings Yield | 2.63% |
| PEGY Ratio | 0.3240 |
| Operating PE Ratio | 39.87 |
| Normalized PE Ratio | 38.97 |